Cargando…

The integration of bevacizumab improves tumor response and survival in patients with refractory cervical cancer treated with radical chemoradiotherapy

BACKGROUND: Management of refractory cervical cancers (CC) is a debated question and rises dilemma in clinical practice. This study aimed to assess the safety and effectiveness of bevacizumab combined with concurrent chemoradiotherapy in the treatment of refractory CC. METHODS: A total of 129 patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hua, Zhang, Ying, Liu, Changhao, Feng, Bin, Zhang, Jianjun, Zhou, Yan, Yin, Yutian, Li, Jianping, Li, Weiwei, Balaya, Vincent, Shi, Mei, Zhao, Lina, Wei, Lichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350679/ https://www.ncbi.nlm.nih.gov/pubmed/34430625 http://dx.doi.org/10.21037/atm-21-3521

Ejemplares similares

Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer
por: Li, Weiwei, et al.
Publicado: (2023)

Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women
por: Wang, Weiping, et al.
Publicado: (2017)

Chemoradiotherapy in combination with radical surgery is associated with better outcome in cervical cancer patients
por: Zheng, Dan, et al.
Publicado: (2017)

Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites
por: Kou, Furong, et al.
Publicado: (2021)

Perioperative morbidity of radical trachelectomy with lymphadenectomy in early-stage cervical cancer: a French prospective multicentric cohort
por: Balaya, Vincent, et al.
Publicado: (2018)

Clinical use of Bevacizumab in treating refractory glaucoma
por: Popescu, V, et al.
Publicado: (2015)

The Clinical Aspects and Prognostic Factors Concerning Survival in Patients With Recurrent Cervical Cancer After Radical Hysterectomy and Adjuvant Chemoradiotherapy
por: Zhu, Hui-Ting, et al.
Publicado: (2022)

Nomogram Predicting the Likelihood of Parametrial Involvement in Early-Stage Cervical Cancer: Avoiding Unjustified Radical Hysterectomies
por: Benoit, Louise, et al.
Publicado: (2020)

Comparison between radical surgery and chemoradiotherapy in patients with cervical esophageal cancer: a propensity score matched analysis
por: Qi, Kang, et al.
Publicado: (2023)

Potential (18)F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and Chemoradiotherapy
por: Li, Li, et al.
Publicado: (2022)

Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study
por: Koulis, Theodora A., et al.
Publicado: (2017)

Nomograms Predicting Survival of Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy Based on the 2018 FIGO Staging System
por: Meng, Qingyu, et al.
Publicado: (2022)

Severe muscle loss during radical chemoradiotherapy for non‐metastatic nasopharyngeal carcinoma predicts poor survival
por: Huang, Xiao, et al.
Publicado: (2019)

Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor
por: Kim, Hakyoung, et al.
Publicado: (2019)

MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy
por: Zhang, Xiaomiao, et al.
Publicado: (2022)

Bevacizumab in the therapy for refractory metastatic colorectal cancer
por: Mulcahy, Mary F
Publicado: (2008)

Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
por: Britton, Anna Krystyna, et al.
Publicado: (2020)

Comparison of concurrent chemoradiotherapy followed by radical surgery and high-dose-rate intracavitary brachytherapy: a retrospective study of 240 patients with FIGO stage IIB cervical carcinoma
por: Wang, Ning, et al.
Publicado: (2014)

Adjuvant chemoradiotherapy for patients with pathologic node-positive esophageal cancer following radical resection is associated with improved survival
por: Zheng, Bin, et al.
Publicado: (2020)

The Prognostic Value of Tumor Size, Volume and Tumor Volume Reduction Rate During Concurrent Chemoradiotherapy in Patients With Cervical Cancer
por: Sun, Chang, et al.
Publicado: (2022)

Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy
por: Sun, Wenze, et al.
Publicado: (2015)

A Case of Cardiac Amyloidosis With Diuretic-Refractory Pleural Effusions Treated With Bevacizumab
por: Bae, Suk-Hyang, et al.
Publicado: (2010)

Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab
por: Voss, Martin, et al.
Publicado: (2019)

Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series
por: Ansstas, George, et al.
Publicado: (2016)

Surveillance Epidemiology and End Results Analysis Demonstrates Improvement in Overall Survival for Cervical Cancer Patients Treated in the Era of Concurrent Chemoradiotherapy
por: Hsu, Howard C., et al.
Publicado: (2015)

Survival benefits from concomitant chemoradiotherapy before radical surgery in stage IVA sinonasal mucosal melanoma?
por: Hafström, Anna, et al.
Publicado: (2019)

Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy
por: Stuopelytė, Raminta, et al.
Publicado: (2023)

Comparison of chemoradiotherapy with and without brachytherapy as adjuvant therapy after radical surgery in early-stage cervical cancer with poor prognostic factors: An observational study
por: Lan, Mei-Ling, et al.
Publicado: (2017)

Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer
por: Zhang, Shu, et al.
Publicado: (2021)

Intravitreal Bevacizumab for Treatment of Refractory Central Serous Choroidoretinopathy
por: Entezari, Morteza, et al.
Publicado: (2012)

Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
por: Ahn, Ye Jin, et al.
Publicado: (2014)

The efficiency of subconjunctival bevacizumab in refractory glaucoma - case report
por: Popescu, V, et al.
Publicado: (2015)

Bevacizumab for Treatment-Refractory Pain Control in Neurofibromatosis Patients
por: Linda, Xu W, et al.
Publicado: (2016)

Survival outcomes of abdominal radical hysterectomy, laparoscopic radical hysterectomy, robot-assisted radical hysterectomy and vaginal radical hysterectomy approaches for early-stage cervical cancer: a retrospective study
por: Zhang, Nina, et al.
Publicado: (2023)

Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits
por: Zamorano, Abigail S., et al.
Publicado: (2017)

Nomograms predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases
por: Wang, Weiping, et al.
Publicado: (2019)

Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment
por: Darmon, Ilan, et al.
Publicado: (2017)

Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection
por: Yuan, Yan, et al.
Publicado: (2021)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis
por: Lan, Mei, et al.
Publicado: (2017)

Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer
por: Zhang, Ying, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_aenlk01o8905jnavh4isf5r5r9